Cooper Financial Group »

Regeneron Pharmaceuticals shares owned by Cooper Financial Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Cooper Financial Group from 13F filings

Historical chart of Cooper Financial Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Cooper Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Cooper Financial Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $293k 279 1051.03
2022-03-31 $386k 553 698.01

More positions owned by Cooper Financial Group

Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Intermed Term (BIV)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Amazon (AMZN)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
NVIDIA Corporation (NVDA)
Global X Fds Us Infr Dev Etf (PAVE)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Douglas Emmett (DEI)

View all positions for Cooper Financial Group

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Bank of America Corporation
Goldman Sachs Group
T. Rowe Price Associates
Invesco
Bank of New York Mellon
American Century Companies
Alliancebernstein

View all funds holding Regeneron Pharmaceuticals